XM does not provide services to residents of the United States of America.

Daily Market Comment – Stocks soar as markets look past Omicron; BoC meeting eyed



  • Optimism prevails as investors see glass half full over Omicron threat
  • Asia lifted by Wall Street jump but futures point to some easing in rally
  • FX markets mostly steady, loonie at 2-week high ahead of BoC decision

Fading Omicron risks boost sentiment

Pre-Christmas cheer came early for equity markets as investors celebrated the growing view that the newly discovered Omicron variant is not more dangerous than the Delta strain. Early evidence suggests that Omicron causes less severe illness than the other variants even though it appears to be the most contagious form of Covid yet.

So far, traders have been embracing the slightest bit of positive news about Omicron, welcoming a preliminary study that shows the Pfizer-BioNTech vaccine offers some protection even though it is significantly less than for other variants. News that a new antibody-based treatment drug is effective against the Omicron strain further reinforced hopes that drastic virus restrictions won’t be necessary.

Stocks heading for more gains but momentum is easing

With investors optimistic that the Omicron outbreak won’t significantly dampen the festivities and lead to winter-long lockdowns, risk assets have bounced back from last week’s panic selloff. Even the tech-heavy Nasdaq posted an incredible rally on Tuesday, surging 3%, despite Treasury yields also rebounding quite strongly.

The S&P 500 closed up 2%, while the Dow Jones finished the session 1.4% higher. Asian shares extended the rally today as monetary easing in China lifted sentiment, offsetting the worrying trend of a lengthening list of local property developers missing their debt payment deadlines.

China has announced a series of measures in recent days aimed at reviving the property sector as well as boosting overall growth in the economy. China’s benchmark stock indices were up more than 1% today, though they’ve been lagging their Asian and global peers all year.

In contrast, the Chinese yuan has been steadily firming in recent months, hitting a 3½-year high versus the US dollar today.

In Europe, stocks opened mixed and US e-mini futures were also pointing to some moderation of the upside momentum.

Dollar mixed, loonie holds near highs ahead of BoC

There was a mixed mood in FX markets on Wednesday as the US dollar lacked a clear direction amid some caution ahead of Friday’s CPI data out of the US and the FOMC meeting next week.

The Australian dollar was the only one from the commodity-linked currencies that was able to stretch its advances against the greenback, climbing to a one-week high of $0.7143.

Relief over the Omicron variant not being as dangerous as first feared has been driving the riskier currencies higher this week, with the aussie and loonie being the main beneficiaries of the improving mood.

The Canadian dollar brushed a fresh two-week high at the start of the session before pulling back slightly. The latest robust employment and trade data out of Canada, combined with waning worries about Omicron and soaring oil prices, have strengthened expectations that the Bank of Canada will sound upbeat at its policy meeting today.

The BoC announces its decision at 15:00 GMT and investors will be looking for clues that policymakers are considering bringing forward their rate hike timeline.

Euro and gold inch higher

The New Zealand dollar also turned lower after a positive open on Wednesday. The kiwi’s paltry rebound this week has been disappointing, but sterling’s performance has been even worse. The euro, however, found itself on a steadier footing after staging a surprise bounce-back on Tuesday.

In commodities, gold edged up for a second day, rising towards $1,790/oz amid some geopolitical tensions between the US and Russia over Ukraine. US President Biden held a two-hour video call with Russian president, Vladimir Putin, yesterday, though it’s unclear whether the meeting will lead to a de-escalation of the situation.

Disclaimer: The XM Group entities provide execution-only service and access to our Online Trading Facility, permitting a person to view and/or use the content available on or via the website, is not intended to change or expand on this, nor does it change or expand on this. Such access and use are always subject to: (i) Terms and Conditions; (ii) Risk Warnings; and (iii) Full Disclaimer. Such content is therefore provided as no more than general information. Particularly, please be aware that the contents of our Online Trading Facility are neither a solicitation, nor an offer to enter any transactions on the financial markets. Trading on any financial market involves a significant level of risk to your capital.

All material published on our Online Trading Facility is intended for educational/informational purposes only, and does not contain – nor should it be considered as containing – financial, investment tax or trading advice and recommendations; or a record of our trading prices; or an offer of, or solicitation for, a transaction in any financial instruments; or unsolicited financial promotions to you.

Any third-party content, as well as content prepared by XM, such as: opinions, news, research, analyses, prices and other information or links to third-party sites contained on this website are provided on an “as-is” basis, as general market commentary, and do not constitute investment advice. To the extent that any content is construed as investment research, you must note and accept that the content was not intended to and has not been prepared in accordance with legal requirements designed to promote the independence of investment research and as such, it would be considered as marketing communication under the relevant laws and regulations. Please ensure that you have read and understood our Notification on Non-Independent Investment. Research and Risk Warning concerning the foregoing information, which can be accessed here.

Risk Warning: Your capital is at risk. Leveraged products may not be suitable for everyone. Please consider our Risk Disclosure.